TIAA CREF Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.53M | Sell |
12,173
-682
| -5% | -$85.4K | ﹤0.01% | 2130 |
|
|
2018
Q4 | $1.45M | Sell |
12,855
-348
| -3% | -$39.2K | ﹤0.01% | 2134 |
|
|
2018
Q3 | $2.83M | Buy |
13,203
+434
| +3% | +$92.9K | ﹤0.01% | 1945 |
|
|
2018
Q2 | $3.57M | Buy |
12,769
+4,727
| +59% | +$1.32M | ﹤0.01% | 1840 |
|
|
2018
Q1 | $939K | Sell |
8,042
-16,147
| -67% | -$1.89M | ﹤0.01% | 2473 |
|
|
2017
Q4 | $2.22M | Buy |
24,189
+15,885
| +191% | +$1.46M | ﹤0.01% | 2079 |
|
|
2017
Q3 | $374K | Buy |
8,304
+950
| +13% | +$42.8K | ﹤0.01% | 2944 |
|
|
2017
Q2 | $120K | Buy |
+7,354
| New | +$120K | ﹤0.01% | 3103 |
|
|
2015
Q4 | – | Sell |
-8,824
| Closed | -$537K | – | 3145 |
|
|
2015
Q3 | $537K | Buy |
8,824
+1,394
| +19% | +$84.8K | ﹤0.01% | 2865 |
|
|
2015
Q2 | $580K | Buy |
7,430
+915
| +14% | +$71.4K | ﹤0.01% | 2920 |
|
|
2015
Q1 | $442K | Hold |
6,515
| – | – | ﹤0.01% | 2956 |
|
|
2014
Q4 | $604K | Buy |
6,515
+158
| +2% | +$14.6K | ﹤0.01% | 2904 |
|
|
2014
Q3 | $670K | Sell |
6,357
-16
| -0.3% | -$1.69K | ﹤0.01% | 2846 |
|
|
2014
Q2 | $912K | Buy |
6,373
+395
| +7% | +$56.5K | ﹤0.01% | 2768 |
|
|
2014
Q1 | $902K | Sell |
5,978
-187
| -3% | -$28.2K | ﹤0.01% | 2697 |
|
|
2013
Q4 | $1.13M | Buy |
6,165
+1,817
| +42% | +$333K | ﹤0.01% | 2594 |
|
|
2013
Q3 | $960K | Sell |
4,348
-142
| -3% | -$31.4K | ﹤0.01% | 2631 |
|
|
2013
Q2 | $784K | Buy |
+4,490
| New | +$784K | ﹤0.01% | 2734 |
|